↓ Skip to main content

Dove Medical Press

Review of Adjuvant Therapies in Renal Cell Carcinoma: Evidence to Date

Overview of attention for article published in OncoTargets and therapy, November 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
32 Mendeley
Title
Review of Adjuvant Therapies in Renal Cell Carcinoma: Evidence to Date
Published in
OncoTargets and therapy, November 2020
DOI 10.2147/ott.s174149
Pubmed ID
Authors

Eliana M C Tacconi, Mark Tuthill, Andrew Protheroe

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 13%
Student > Bachelor 3 9%
Professor 3 9%
Other 2 6%
Student > Doctoral Student 2 6%
Other 4 13%
Unknown 14 44%
Readers by discipline Count As %
Medicine and Dentistry 12 38%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Unspecified 1 3%
Nursing and Health Professions 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 0 0%
Unknown 16 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2023.
All research outputs
#8,039,503
of 25,584,565 outputs
Outputs from OncoTargets and therapy
#432
of 2,967 outputs
Outputs of similar age
#167,959
of 442,270 outputs
Outputs of similar age from OncoTargets and therapy
#10
of 98 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 2,967 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,270 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.